C.M. Bidwell & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-770
| Closed | -$48K | – | 507 |
|
|
2020
Q4 | $48K | Sell |
770
-185
| -19% | -$11.5K | 0.04% | 290 |
|
|
2020
Q3 | $58K | Sell |
955
-80
| -8% | -$4.86K | 0.05% | 248 |
|
|
2020
Q2 | $61K | Buy |
+1,035
| New | +$61K | 0.06% | 245 |
|
|
2020
Q1 | – | Sell |
-7,265
| Closed | -$466K | – | 363 |
|
|
2019
Q4 | $466K | Buy |
+7,265
| New | +$466K | 0.42% | 58 |
|
|
2019
Q1 | – | Sell |
-4,470
| Closed | -$232K | – | 401 |
|
|
2018
Q4 | $232K | Buy |
+4,470
| New | +$232K | 0.25% | 105 |
|
|
2017
Q1 | – | Sell |
-5,410
| Closed | -$316K | – | 231 |
|
|
2016
Q4 | $316K | Buy |
+5,410
| New | +$316K | 0.07% | 121 |
|
|
2015
Q2 | – | Sell |
-50
| Closed | -$3K | – | 218 |
|
|
2015
Q1 | $3K | Sell |
50
-5,415
| -99% | -$325K | ﹤0.01% | 207 |
|
|
2014
Q4 | $323K | Sell |
5,465
-1,790
| -25% | -$106K | 0.07% | 117 |
|
|
2014
Q3 | $371K | Buy |
7,255
+1,350
| +23% | +$69K | 0.09% | 105 |
|
|
2014
Q2 | $286K | Hold |
5,905
| – | – | 0.07% | 119 |
|
|
2014
Q1 | $307K | Buy |
+5,905
| New | +$307K | 0.07% | 111 |
|